Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000751

Type of data
NGS (Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
40.8 GB
File formats
  • BAM
Research
hum0403
Date published
2023-07-01
Date modified
2023-07-01
DDBJ Search
JGAD000751 (opens in a new tab)
JGA Study
JGAS000622 (opens in a new tab)

Unrestricted-access files linked to this dataset

Download the URL list
FileLabelSizeCopy URL
AVENIO_ctDNA_Expanded_Kit_Assay_Target.xlsx77 genes10.7 KB

Analysis method

Targeted DNA sequencing

Materials and participants
metastatic urothelial carcinoma (ICD10: C65, C66, C67.9): 16 cases
16 plasma samples collected before immune checkpoint inhibitor treatment
9 plasma samples collected after immune checkpoint inhibitor treatment
  • Health status
    Affected
  • Subject count
    25 (Mixed)
Disease
metastatic urothelial carcinoma (C65, C66, C679)
Sample description
cell-free DNA in plasma
  • Tissue
    cfDNA
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
77 genes
Reagent kit
AVENIO ctDNA Expanded Kit
Fragmentation
N/A
Platform
Illumina NextSeq 500
Read type
Paired-end
Read length
151 bp
Reference genome
GRCh38
Mapping
AVENIO ctDNA Analysis Software Version 2.0.0
Mapping quality
99.99997595
Coverage (depth)
7243x
Data use policy
NBDC data sharing policy (JGAP000001)